Clinical trial
Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
NCT01861613 is registered in ClinicalTrials.gov with Hui Zhuang as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Seroprevalence of Hepatitis B and Immune Response to Hepatitis B Vaccination in Chinese College Students
- Lead sponsor
- Hui Zhuang
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- September 30, 2009
- Completion date
- Not reported
- Enrollment
- 2,040 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b, immune response, seroprevalence